Orange Biomed

Orange Biomed Orange Biomed was launched in 2021 by Duke University alumnus Dr. Unghyeon Ko and Yeaseul Park to solve unmet diabetes-focused healthcare needs.

The healthcare startup innovates cutting-edge technology for diabetes management, including OBM rapid A1c. Orange Biomed is currently conducting research studies for OBM rapid A1c at Seoul Asan Medical Center. Asan is South Korea's largest hospital and is backed by the Hyundai group, one of Korea's largest conglomerates with a strong emphasis on healthcare.

Address

1065 Wordens Pond Rd
Wakefield, RI
02879

Website

Alerts

Be the first to know and let us send you an email when Orange Biomed posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share

Category